Fifty years devoted to anaerobes: historical, lessons, and highlights

Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):1-15. doi: 10.1007/s10096-023-04708-4. Epub 2023 Nov 16.

Abstract

Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection. Prevotella, fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections, Bacteroides of the fragilis group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.

Keywords: Anaerobic bacteria; Anaerobic infections; Antibiotic susceptibility testing; Clinical outcome; Resistance mechanism.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria, Anaerobic
  • Bacterial Infections* / drug therapy
  • Bacterial Infections* / microbiology
  • Clostridium
  • Drug Resistance, Bacterial
  • Gram-Positive Cocci*
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents